NuCana plc (NCNA)
Nasdaq: NCNA · Pharmaceutical Preparations · Edinburgh, GB · filing with the SEC since 2017
Who runs NuCana plc
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Griffith Hugh
Chief Executive Officer. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
5
of 9 people with a filing in the last fifteen months
Directors reporting now
4
9 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bloss Jeffrey D. | Chief Medical Officer | Mar 2026 | Jun 23, 2026 | none |
| Bruce Theresa Margaret Ms | Chief Operating Officer | Mar 2026 | Apr 16, 2026 | none |
| Harrison David James | Head of Translational Medicine | Mar 2026 | Mar 24, 2026 | none |
| Griffith Hugh | Chief Executive Officer | Mar 2026 | Mar 18, 2026 | none |
| Webster Ian Alexander | Exhibit 24.1 - Power of Attorney Interim Chief Financial Officer | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Levy Elliott M. | director | Apr 2026 | Jun 24, 2026 | none |
| Mellish Martin C.B. | director | Mar 2026 | Mar 20, 2026 | none |
| Kay Andrew Martin | director | Mar 2026 | Mar 18, 2026 | none |
| Leperlier Cyrille | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.